Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...

Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a ...

Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...

The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...

Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big Pharma after GSK (NYSE:GSK) to revise DEI initiatives amid the Trump ...

Signal transducer and activator of transcription 6 (STAT6) is a member of the STAT family involved in the regulation of ... Researchers from Recludix Pharma Inc. have presented the preclinical ...

(STAT News) Major drugmakers plan to meet with President Trump next week amid health shakeups. The meeting is reportedly to be led by pharma CEOs that include Pfizer’s Albert Bourla, Merck’s Rob Davis ...

After a Canadian regulator began requiring application fees from drug companies more than a decade ago, the odds that a drug — other than cancer treatments — would receive a recommendation for ...